The use of ketamine as adjuvant therapy to control severe pain

Clinical Journal of Oncology Nursing

Volumn 12, Issue 1, 2008, Pages 102-107

  Campbell Fleming, Janis M ^a   Williams, Amy ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID RECEPTOR BLOCKING AGENT; ANALGESIC AGENT; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NARCOTIC ANALGESIC AGENT;

ADULT; CASE REPORT; CHEMISTRY; DRUG ANTAGONISM; DRUG COMBINATION; DRUG MONITORING; FEMALE; HUMAN; METHODOLOGY; NEOPLASM; NURSE ATTITUDE; NURSING; ONCOLOGY NURSING; PAIN; PAIN ASSESSMENT; PATIENT CONTROLLED ANALGESIA; REVIEW; TERMINAL CARE;

ADULT; ANALGESIA, PATIENT-CONTROLLED; ANALGESICS; ANALGESICS, OPIOID; DRUG MONITORING; DRUG THERAPY, COMBINATION; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HUMANS; KETAMINE; NEOPLASMS; NURSE'S ROLE; ONCOLOGIC NURSING; PAIN; PAIN MEASUREMENT; RECEPTORS, N-METHYL-D-ASPARTATE; TERMINAL CARE;

EID: 42949117017     PISSN: 10921095     EISSN: 1538067X     Source Type: Journal    
DOI: 10.1188/08.CJON.102-107     Document Type: Article

References (24)

1. Bell, R.F., Eccleston, C., & Kalso, E. (2003). Ketamine as adjuvant to opioids for cancer pain: A qualitative systematic review. Journal of Pain and Symptom Management, 26(3), 867-875.
2. Bentley, M.W., Stas, J.M., Johnson, J.M., Viet, B.C., & Garrett, N. (2005). Effects of preincisional ketamine treatment on natural killer cell activity and postoperative pain management after oral maxillofacial surgery. AANA Journal, 73(6), 427-436.
3. Brunner, L.S., Suddarth, D.S., Smeltzer, S.C., & Bare, B.G. (2004). Brunner and Suddarth's textbook of medical-surgical nursing (10th ed.). Philadelphia: Lippincott Williams and Wilkins.
4. Chowdhury, S. (2006). An exploration into the pharmacology of analgesics. Nurse Prescribing, 4(1), 32-37.
5. Cohen, S.P., & DeJesus, M. (2004). Ketamine patient-controlled analgesia for dysesthetic central pain. Spinal Cord, 42(7), 425-428.
6. Coluzzi, P.H., Schwartzberg, L., Conroy, J.D., Charapata, S., Gay, M., Busch, M.A., et al. (2001). Breakthrough cancer pain: A randomized trial comparing oral transmucosal fentanyl citrate (OTFC) and morphine sulfate immediate release (MSIR). Pain, 91(1-2), 123-130.
7. Correll, G.E., Maleki, J., Gracely, E.J., Muir, J.J., & Harbut, R.E. (2004). Subanesthetic ketamine infusion therapy: A retrospective analysis of a novel therapeutic approach to complex regional pain syndrome. Pain Medicine, 5(3), 263-275.
8. Enting, R.H., Mucchianno, C., Oldenmenger, W.H., Fritzon, M., Wal-len, A., Goslinga-van der Gaag, S., et al. (2005). The "pain pen" for breakthrough cancer pain: A promising treatment. Journal of Pain and Symptom Management, 29(2), 213-217.
9. Fine, P.G. (1999). Low-dose ketamine in the management of opioid nonresponsive terminal cancer pain. Journal of Pain and Symptom Management, 17(4), 296-300.
10. Finlay, I. (1999). Ketamine and its role in cancer pain. Pain Reviews, 6(4), 303-313.
11. Fitzgibbon, E.J., & Viola, R. (2005). Parenteral ketamine as an analgesic adjuvant for severe pain: Development and retrospective audit of a protocol for a palliative care unit. Journal of Palliative Medicine, 8(1), 49-57.
12. Good, P., Tullio, F., Jackson, K., Goodchild, C., & Ashby, M. (2005). Prospective audit of short-term concurrent ketamine, opioid and anti-infammatory ('triple-agent') therapy for episodes of acute and chronic pain. Internal Medicine Journal, 35(1), 39-44.
13. Indelicato, R.A., & Portenoy, R.K. (2003). Opioid rotation in the management of refractory cancer pain. Journal of Clinical Oncology, 21(9, Suppl.), 87s-91s.
14. Levy, M.H. (1996). Pharmacologic treatment of cancer pain. New England Journal of Medicine, 335(15), 1124-1132.
15. Mercadante, S., Villari, P., & Ferrera, P. (2003). Burst ketamine to reverse opioid tolerance in cancer pain [Letter to the editor]. Journal of Pain and Symptom Management, 25(4), 302-305.
16. Moore, K., & Measham, F. (2006). Ketamine use: Minimising problems and maximising pleasure. Drugs and Alcohol Today, 6(3), 29-32.
17. Mystakidou, K., Tsilika, E., Parpa, E., Pathiaki, M., Patiraki, E., Galanos, A., et al. (2007). Exploring the relationships between depression, hopelessness, cognitive status, pain, and spirituality in patients with advanced cancer. Archives of Psychiatric Nursing, 21(3), 150-161.
18. Otto, S.E. (2001). Lung cancers. In S.E. Otto (Ed.), Oncology nursing (4th ed., pp. 380-415). St. Louis, MO: Mosby.
19. Pasero, C., & McCaffery, M. (2005). Ketamine: Low doses may provide relief for some painful conditions. American Journal of Nursing, 105(4), 60-64.
20. Portenoy, R.K., Taylor, D., Messina, J., & Tremmel, L. (2006). A randomized, placebo-controlled study of fentanyl buccal tablet for breakthrough pain in opioid-treated patients with cancer. Clinical Journal of Pain, 22(9), 805-811.
21. Sen, S., Aydin, O.N., & Aydin, K. (2006). Beneficial effect of low-dose ketamine addition to epidural administration of morphine-bupivacaine mixture for cancer pain in two cases. Pain Medicine, 7(2), 166-169.
22. Souter, K.J., Davies, J.M., Loeser, J.D., & Fitzgibbon, D.R. (2005). Continuous intrathecal meperidine for severe refractory cancer pain: A case report. Clinical Journal of Pain, 21(2), 193-196.
23. Sun, M.Y., Canete, J.J., Friel, J.C., McDade, J., Singla, S., Paterson, C.A., et al. (2006). Combination propofol/ketamine is a safe and efficient anesthetic approach to anorectal surgery. Disease of the Colon and Rectum, 49(7), 1059-1065.
24. Swenson, C.J. (2001). Pain management. In S.E. Otto (Ed.), Oncology nursing (pp. 865-917). St. Louis, MO: Mosby.